Enterprise B2B Terms for UESE Precision Bio AI

1. Subject Matter, Contract Structure and Document Priority

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

Requests are prioritised by impact and urgency. Response time measures acknowledgement and engagement, not necessarily resolution; critical priorities require defined escalation channels, contacts and minimum diagnostic information.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

For enterprise deployments, the decision should be translated into a RACI matrix, verifiable evidence, acceptance criteria, technical controls and periodic review; exceptions must be approved, reasoned, time-limited and traceable.

2. Eligible Customers and Professional Nature

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

Access is intended for organisations and professionals acting in the course of their activities. The customer must ensure that users, researchers and collaborators are authorised and appropriately trained; involvement of consumers, patients or non-professional users requires a separate contractual and regulatory assessment.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

In healthcare or multi-centre projects, the requirement should be linked to the protocol, decision record, DPIA or security file where relevant, avoiding any assumption that a technical configuration replaces legal or scientific assessment.

3. Activation, Provisioning and Preconditions

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

Compliance is continuous: changes to purpose, data, suppliers, engines, hosting, integrations or law require impact assessment and, where needed, updates to contracts, controls, instructions and documentation.

4. Accounts, Credentials and User Responsibilities

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

Accounts are personal and must not be shared. The customer must promptly manage onboarding, role changes and de-provisioning; privileged access requires enhanced controls and, where policy requires, multi-factor authentication. Traceability is undermined where multiple people use the same identity.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

UESE retains evidence proportionate to function and risk. The customer organisation remains responsible for its authorisations, protocols, legal bases and healthcare or scientific decisions beyond the service scope entrusted to UESE.

5. Roles, Permissions and Organisational Segregation

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

For enterprise deployments, the decision should be translated into a RACI matrix, verifiable evidence, acceptance criteria, technical controls and periodic review; exceptions must be approved, reasoned, time-limited and traceable.

6. Intended Purpose and RUO Scope

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The current intended purpose must be reflected in product materials, manuals and onboarding. Any change introducing a medical, diagnostic, prognostic, predictive or therapeutic purpose requires a new software qualification analysis and, where applicable, an MDR/IVDR pathway and reassessment under the AI Act.

RTO and RPO, if offered, must be expressly stated in the SLA and aligned with the architecture. Without executed values they cannot be inferred from public material; disaster recovery and application restoration should be tested periodically where required by the continuity plan.

In healthcare or multi-centre projects, the requirement should be linked to the protocol, decision record, DPIA or security file where relevant, avoiding any assumption that a technical configuration replaces legal or scientific assessment.

7. Customer Duties Regarding Data, Legal Bases and Consent

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The newsletter is voluntary and separate from commercial or technical enquiries. UESE uses email double opt-in to document the data subject’s choice; unsubscribe is available at any time and withdrawal does not affect the lawfulness of earlier processing.

Legal basis is determined per purpose, not per platform. Pre-contractual activities, contract performance, security, legal obligations and marketing may rely on different grounds; health or genetic data also require an Article 9 condition and, where applicable, research safeguards under Article 89.

Compliance is continuous: changes to purpose, data, suppliers, engines, hosting, integrations or law require impact assessment and, where needed, updates to contracts, controls, instructions and documentation.

8. Health and Genomic Data

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

Health and genetic data are special categories under GDPR Article 9. The controller must identify an Article 6 legal basis and an Article 9 condition, assess applicable health and research law and implement appropriate safeguards; pseudonymisation reduces risk but does not automatically make data anonymous.

FASTQ, BAM/CRAM and large datasets should not pass through ordinary PHP shared-hosting uploads. The platform governs metadata, references, checksums and permissions, while large payloads belong in authorised storage under territorial and contractual conditions compatible with the project.

UESE retains evidence proportionate to function and risk. The customer organisation remains responsible for its authorisations, protocols, legal bases and healthcare or scientific decisions beyond the service scope entrusted to UESE.

9. Integrations, APIs and External Systems

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

Integrations must be inventoried and authorised. The customer must determine what data may leave its environment, which credentials are used, who governs APIs and which terms apply to the recipient; tokens, endpoints and secrets must be managed with least privilege and appropriate rotation.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

For enterprise deployments, the decision should be translated into a RACI matrix, verifiable evidence, acceptance criteria, technical controls and periodic review; exceptions must be approved, reasoned, time-limited and traceable.

10. Security and Cooperation

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

In healthcare or multi-centre projects, the requirement should be linked to the protocol, decision record, DPIA or security file where relevant, avoiding any assumption that a technical configuration replaces legal or scientific assessment.

11. Continuity, Maintenance and Technical Changes

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

Compliance is continuous: changes to purpose, data, suppliers, engines, hosting, integrations or law require impact assessment and, where needed, updates to contracts, controls, instructions and documentation.

12. Support and Service Levels

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

UESE retains evidence proportionate to function and risk. The customer organisation remains responsible for its authorisations, protocols, legal bases and healthcare or scientific decisions beyond the service scope entrusted to UESE.

13. Intellectual Property and Right of Use

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The UESE Precision Bio AI platform, its proprietary source code, application architecture, interfaces, original documentation, trademarks, graphical elements and components specifically developed for the product are owned by UESE ITALIA S.p.A., without prejudice to open-source libraries, standards, third-party components or technologies, which remain subject to the rights and licences of their respective owners. The Project Lead is dr. Giuseppe Izzo. The customer receives only the contractual right of use; unauthorised reverse engineering, systematic extraction, sublicensing or exploitation is prohibited to the extent permitted by law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

For enterprise deployments, the decision should be translated into a RACI matrix, verifiable evidence, acceptance criteria, technical controls and periodic review; exceptions must be approved, reasoned, time-limited and traceable.

14. Customer Data, Outputs and Portability

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

Retention periods are defined by data category and purpose. Exit must distinguish export, return, logical deletion, storage deletion and backup cycles; legal duties, disputes or legal hold may justify limited segregated retention that is documented and not reused for other purposes.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

In healthcare or multi-centre projects, the requirement should be linked to the protocol, decision record, DPIA or security file where relevant, avoiding any assumption that a technical configuration replaces legal or scientific assessment.

15. Confidentiality and Confidential Information

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

Compliance is continuous: changes to purpose, data, suppliers, engines, hosting, integrations or law require impact assessment and, where needed, updates to contracts, controls, instructions and documentation.

16. Fees, Taxes and Commercial Terms

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

UESE retains evidence proportionate to function and risk. The customer organisation remains responsible for its authorisations, protocols, legal bases and healthcare or scientific decisions beyond the service scope entrusted to UESE.

17. Suspension for Risk, Abuse or Breach

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

Events are classified by severity and impact, contained and documented. Where UESE acts as processor it notifies the controller without undue delay after becoming aware of a personal data breach and provides available information for GDPR Articles 33 and 34 assessments; regulatory notifications remain with the competent party.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

For enterprise deployments, the decision should be translated into a RACI matrix, verifiable evidence, acceptance criteria, technical controls and periodic review; exceptions must be approved, reasoned, time-limited and traceable.

18. Term, Termination and Exit

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

In healthcare or multi-centre projects, the requirement should be linked to the protocol, decision record, DPIA or security file where relevant, avoiding any assumption that a technical configuration replaces legal or scientific assessment.

19. Data Return, Export and Deletion

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

Retention periods are defined by data category and purpose. Exit must distinguish export, return, logical deletion, storage deletion and backup cycles; legal duties, disputes or legal hold may justify limited segregated retention that is documented and not reused for other purposes.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

Compliance is continuous: changes to purpose, data, suppliers, engines, hosting, integrations or law require impact assessment and, where needed, updates to contracts, controls, instructions and documentation.

20. Warranties, Exclusions and Liability

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

UESE retains evidence proportionate to function and risk. The customer organisation remains responsible for its authorisations, protocols, legal bases and healthcare or scientific decisions beyond the service scope entrusted to UESE.

21. Compliance, Audit and Regulatory Cooperation

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

For enterprise deployments, the decision should be translated into a RACI matrix, verifiable evidence, acceptance criteria, technical controls and periodic review; exceptions must be approved, reasoned, time-limited and traceable.

22. Applicable Law, Disputes and Amendments

These terms provide the general B2B framework for professional access to UESE Precision Bio AI. The actual relationship is completed by the signed proposal, order, technical specifications, data processing agreement, service levels, project protocol and other executed documents; customer-specific provisions prevail in case of conflict, subject to mandatory law.

The governing agreement determines applicable law and jurisdiction to the extent permitted by mandatory rules. Non-derogable powers of supervisory authorities and EU or national provisions that apply regardless of contractual choice remain unaffected.

The customer is responsible for its configuration, data, user authorisations and lawful purposes. UESE is responsible for obligations expressly assumed and cooperates under the contract, without taking over scientific, clinical or organisational decisions reserved to the customer.

In healthcare or multi-centre projects, the requirement should be linked to the protocol, decision record, DPIA or security file where relevant, avoiding any assumption that a technical configuration replaces legal or scientific assessment.